| May-25-22 08:26AM |
Genocea Biosciences to shut down |
MarketWatch |
| May-24-22 12:25PM |
Three weeks after layoffs, Genocea shuts down entirely |
American City Business Journals |
| May-24-22 09:31AM |
Genocea Closes Shop, Delists From NASDAQ |
Benzinga |
| May-24-22 08:00AM |
Genocea Announces Wind Down of Operations and Delisting From NASDAQ |
GlobeNewswire |
| May-02-22 01:20PM |
Genocea cuts two-thirds of staff, explores a sale |
American City Business Journals |
| Apr-28-22 04:05PM |
Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives |
GlobeNewswire |
| Apr-11-22 08:49AM |
Implied Volatility Surging for Genocea (GNCA) Stock Options |
Zacks |
| Apr-08-22 02:32PM |
Genocea Biosciences Stock Dives After Early Data From GEN-011 Trial In Pretreated Solid Tumor Patients |
Benzinga |
| Apr-08-22 01:05PM |
Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022 |
GlobeNewswire |
| Apr-04-22 08:07AM |
Genocea Biosciences to Host Investor Webinar |
GlobeNewswire |
| Mar-14-22 05:06PM |
Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference |
GlobeNewswire |
| Mar-10-22 07:00AM |
Genocea Provides Fourth Quarter 2021 Corporate Update |
GlobeNewswire |
| Mar-08-22 05:39PM |
Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting |
GlobeNewswire |
| Mar-07-22 04:05PM |
John Lunger, of Adaptimmune, Joins Genocea Biosciences' Board of Directors |
GlobeNewswire |
| Mar-03-22 08:00AM |
Genocea to Host Fourth Quarter 2021 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Feb-10-22 07:50PM |
Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference |
GlobeNewswire |
| Jan-06-22 05:36AM |
The Petri Dish: Janssen inks two local deals, Biogen licenses new drug |
American City Business Journals |
| Jan-05-22 05:46PM |
Genocea to Present at Upcoming Investor Conferences |
GlobeNewswire |
| Jan-04-22 07:00AM |
Genocea Biosciences Provides Corporate Update |
GlobeNewswire |
| Dec-23-21 07:36AM |
Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday |
InvestorPlace |
| Nov-10-21 07:26PM |
Genocea to Present at the Stifel 2021 Virtual Healthcare Conference |
GlobeNewswire |
| Oct-28-21 07:00AM |
Genocea Provides Third Quarter 2021 Corporate Update |
GlobeNewswire |
| Oct-21-21 04:30PM |
Genocea to Host Third Quarter 2021 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Sep-28-21 04:30PM |
Genocea to Present at Upcoming Conferences |
GlobeNewswire |
| Sep-13-21 04:52PM |
Jennifer Herron, of ADC Therapeutics, Joins Genocea Biosciences' Board of Directors |
GlobeNewswire |
| Sep-07-21 07:40PM |
Genocea to Present at Upcoming Scientific and Investor Conferences |
GlobeNewswire |
| Aug-23-21 08:36AM |
Do Options Traders Know Something About Genocea (GNCA) Stock We Don't? |
Zacks |
| Jul-29-21 07:00AM |
Genocea Provides Second Quarter 2021 Corporate Update |
GlobeNewswire |
| Jul-22-21 05:05PM |
Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Jul-14-21 09:52AM |
Genocea (GNCA) Begins Phase I/IIa Study for Solid Tumor Drug |
Zacks |
| Jul-13-21 10:11AM |
Genocea Biosciences Starts Dosing In Mid-Stage GEN-011 Study In Solid Tumors |
Benzinga |
| Jul-13-21 07:30AM |
Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy |
GlobeNewswire |
| Jul-07-21 08:38AM |
Is the Options Market Predicting a Spike in Genocea (GNCA) Stock? |
Zacks |
| Jun-17-21 05:30AM |
It's Probably Less Likely That Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Will See A Huge Pay Rise This Year |
Simply Wall St. |
| Jun-04-21 09:00AM |
Genocea Presents Promising Long-term Results from GEN-009 Neoantigen Vaccine Phase 1 Trial at ASCO 2021 |
GlobeNewswire |
| May-30-21 04:55AM |
Do Institutions Own Genocea Biosciences, Inc. (NASDAQ:GNCA) Shares? |
Simply Wall St. |
| Apr-29-21 08:55AM |
Genocea Biosciences (GNCA) Reports Q1 Loss, Misses Revenue Estimates |
Zacks |
| Apr-29-21 07:00AM |
Genocea Provides First Quarter 2021 Corporate Update |
GlobeNewswire |
| Apr-29-21 06:30AM |
Genocea Biosciences, Inc. to Host Earnings Call |
ACCESSWIRE |
| Apr-22-21 04:30PM |
Genocea To Host First Quarter 2021 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Apr-10-21 08:30AM |
Genocea to Present Novel Preclinical Inhibigen Data at AACR Annual Meeting 2021 |
GlobeNewswire |
| Apr-06-21 04:30PM |
Genocea to Present at the 20th Annual Needham Virtual Healthcare Conference |
GlobeNewswire |
| Mar-02-21 04:01PM |
Genocea to Present at the H.C. Wainwright Global Life Sciences Conference |
GlobeNewswire |
| Feb-11-21 07:30AM |
Genocea Provides Fourth Quarter 2020 Corporate Update |
GlobeNewswire |
| Feb-11-21 06:30AM |
Genocea Biosciences, Inc. to Host Earnings Call |
ACCESSWIRE |
| Feb-04-21 04:05PM |
Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Jan-28-21 06:00AM |
Genocea Announces Publication in Cancer Discovery Highlighting the Advantages of Neoantigen Identification with the ATLAS Platform |
GlobeNewswire |
| Jan-19-21 06:54PM |
Genocea to Participate in the B. Riley Securities Virtual Oncology Investor Conference |
GlobeNewswire |
| Jan-04-21 04:19PM |
Genocea to Present at the H.C. Wainwright Virtual BioConnect Conference |
GlobeNewswire |
| Dec-28-20 08:42AM |
Is the Options Market Predicting a Spike in Genocea (GNCA) Stock? |
Zacks |
| Dec-21-20 01:24AM |
What Is The Ownership Structure Like For Genocea Biosciences, Inc. (NASDAQ:GNCA)? |
Simply Wall St. |
| Dec-10-20 07:54PM |
Is GNCA A Good Stock To Buy Now? |
Insider Monkey |
| Nov-12-20 08:00AM |
Genocea to Present at the Stifel 2020 Virtual Healthcare Conference |
GlobeNewswire |
| Nov-09-20 08:01AM |
Genocea Presents Positive GEN-009 Clinical Results, Update on GEN-011 Program and New InhibigenTM Mechanism of Action Data at Virtual SITC 2020 |
GlobeNewswire |
| Nov-05-20 06:10PM |
Genocea to Host Investor Call Highlighting New GEN-009 Clinical and Immunogenicity Data to be Presented at Virtual SITC 2020 |
GlobeNewswire |
| Oct-29-20 07:00AM |
Genocea Provides Third Quarter 2020 Corporate Update |
GlobeNewswire |
| Oct-29-20 06:30AM |
Genocea Biosciences, Inc. to Host Earnings Call |
ACCESSWIRE |
| Oct-28-20 03:30PM |
These 3 Penny Stocks Could Rack up Triple-Digit Gains, Says Leerink |
TipRanks |
| Oct-22-20 04:57PM |
Genocea to Host Third Quarter 2020 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Oct-22-20 09:46AM |
Does Genocea Biosciences' (NASDAQ:GNCA) CEO Salary Compare Well With Industry Peers? |
Simply Wall St. |
| Oct-15-20 11:30AM |
Is Genocea Biosciences (GNCA) Stock Outpacing Its Medical Peers This Year? |
Zacks |
| Oct-14-20 05:22PM |
Genocea Announces Upcoming Data Presentations at Virtual SITC 2020 |
GlobeNewswire |
| Sep-23-20 11:40AM |
Genocea to Initiate a Phase I/II Oncology Study on GEN-011 |
Zacks |
| Sep-22-20 09:05AM |
Genocea Up 5% On FDA Nod For Cancer Therapy Application; Street Sees 353% Upside |
SmarterAnalyst |
| Sep-22-20 07:30AM |
Genocea Announces FDA Acceptance of GEN-011 IND Application |
GlobeNewswire |
| Sep-17-20 03:00AM |
Genocea Presents Follow-up Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial at ESMO Virtual Congress 2020 |
GlobeNewswire |
| Sep-15-20 08:07AM |
Are Options Traders Betting on a Big Move in Genocea Biosciences (GNCA) Stock? |
Zacks |
| Sep-03-20 06:53PM |
Genocea to Present at the ESMO Virtual Congress and Two Investor Conferences in September |
GlobeNewswire |
| Jul-30-20 07:00AM |
Genocea to Present Positive Preliminary Clinical Data Evaluating Neoantigen Vaccine GEN-009 in Combination with Checkpoint Inhibitors |
GlobeNewswire |
| Jul-23-20 07:00AM |
Genocea Provides Second Quarter 2020 Corporate Update |
GlobeNewswire |
| Jul-22-20 09:02AM |
Genocea Announces Private Placement Financing of Up to $80 Million |
GlobeNewswire |
| Jul-20-20 08:00AM |
Genocea Biosciences Provides Clinical Update |
GlobeNewswire |
| Jul-16-20 08:00AM |
Genocea to Host Second Quarter 2020 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Jul-06-20 09:27AM |
Genocea Biosciences Inc (GNCA): Are Hedge Funds Right About This Stock? |
Insider Monkey |
| Jun-23-20 03:52PM |
Edited Transcript of GNCA.OQ earnings conference call or presentation 30-Apr-20 12:30pm GMT |
Thomson Reuters StreetEvents |
| Jun-22-20 09:00AM |
Genocea to Present Data that Reveal New Understanding of ATLASTM-Identified InhibigenTM Biology at AACR Virtual Annual Meeting II |
GlobeNewswire |
| Jun-15-20 07:30AM |
Genocea Files IND Application for GEN-011, a T cell Therapy Designed to Improve on Current Limitations of TIL Therapy |
GlobeNewswire |
| May-29-20 08:00AM |
Genocea Presents Updated Long-term Safety, Immunogenicity and Durability Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial Part A at Virtual ASCO 2020 |
GlobeNewswire |
| May-19-20 07:30AM |
Genocea Announces Material Transfer and License Option Agreement with Shionogi for Proprietary GEN-003 HSV-2 Antigens |
GlobeNewswire |
| May-13-20 06:02PM |
Genocea to Present Long-term Follow-up Data from GEN-009 Neoantigen Vaccine at Virtual ASCO 2020 |
GlobeNewswire |
| May-13-20 07:40AM |
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter |
Benzinga |
| May-12-20 05:32PM |
Genocea Introduces GEN-011, a Transformational T cell Therapy Designed to Improve on Current Limitations of TIL Therapy |
GlobeNewswire |
| May-11-20 04:30PM |
REMINDER: Genocea to Host KOL Symposium Highlighting GEN-011s Potential to Transform T cell Therapy for Solid Tumors |
GlobeNewswire |
| May-05-20 04:05PM |
Genocea to Host KOL Symposium Highlighting GEN-011s Potential to Transform T cell Therapy for Solid Tumors |
GlobeNewswire |
| Apr-30-20 07:00AM |
Genocea Provides First Quarter 2020 Corporate Update |
GlobeNewswire |
| Apr-24-20 06:11AM |
Bet on Rising P/E Investing With These Top 5 Stocks |
Zacks |
| Apr-23-20 08:01PM |
Genocea to Host First Quarter 2020 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Apr-23-20 11:44AM |
Genocea Biosciences, Inc. (GNCA) Shares March Higher, Can It Continue? |
Zacks |
| Apr-21-20 07:00AM |
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Genocea Biosciences, Inc. for Potential Breach of Fiduciary Duty Claims |
GlobeNewswire |
| Apr-08-20 04:01PM |
Genocea to Present Virtually at the 19th Annual Needham Healthcare Conference |
GlobeNewswire |
| Feb-26-20 04:05PM |
Genocea to Present at the Cowen & Company 40th Annual Health Care Conference |
GlobeNewswire |
| Feb-20-20 09:15PM |
Edited Transcript of GNCA earnings conference call or presentation 13-Feb-20 1:30pm GMT |
Thomson Reuters StreetEvents |
| Feb-20-20 08:00AM |
Genocea to Present at the SVB Leerink 9th Annual Global Healthcare Conference |
GlobeNewswire |
| Feb-13-20 07:00AM |
Genocea Provides Fourth Quarter 2019 Corporate Update |
GlobeNewswire |
| Feb-06-20 07:30AM |
Genocea to Host Fourth Quarter 2019 Corporate Update Conference Call & Webcast |
GlobeNewswire |
| Dec-14-19 09:43PM |
Genocea Biosciences Inc (GNCA): Hedge Fund Sentiment Unchanged |
Insider Monkey |
| Nov-14-19 05:00PM |
Genocea to Present at the Stifel 2019 Healthcare Conference |
GlobeNewswire |
| Nov-14-19 08:30AM |
Genocea Biosciences Enters Oversold Territory |
Zacks |
| Nov-09-19 09:00AM |
Genocea Preclinical Data at SITC Demonstrate that Inhibitory Neoantigens in an Otherwise Protective Vaccine Reverse Anti-Tumor Responses |
GlobeNewswire |
| Nov-05-19 08:05AM |
Genocea Presents Preclinical Research that Shows Inhibitory Neoantigens Stifle Protective Anti-Tumor Immune Responses at Society for Immunotherapy of Cancer (SITC) |
GlobeNewswire |